Small for gestational age: short stature and beyond

P Saenger, P Czernichow, I Hughes… - Endocrine …, 2007 - academic.oup.com
Depending on the definitions used, up to 10% of all live-born neonates are small for
gestational age (SGA). Although the vast majority of these children show catch-up growth by …

Isolated growth hormone deficiency (GHD) in childhood and adolescence: recent advances

KS Alatzoglou, EA Webb, P Le Tissier… - Endocrine …, 2014 - academic.oup.com
The diagnosis of GH deficiency (GHD) in childhood is a multistep process involving clinical
history, examination with detailed auxology, biochemical testing, and pituitary imaging, with …

Genetic causes and treatment of isolated growth hormone deficiency—an update

KS Alatzoglou, MT Dattani - Nature Reviews Endocrinology, 2010 - nature.com
Isolated growth hormone deficiency is the most common pituitary hormone deficiency and
can result from congenital or acquired causes, although the majority of cases are idiopathic …

Pegvisomant and pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response

S Chiloiro, A Giampietro, F Mirra… - European journal of …, 2021 - academic.oup.com
Background The treatment of acromegaly resistant to first-generation somatostatin receptor
ligands (SRLs) is often difficult. Pegvisomant and Pasireotide LAR are mostly used in these …

Identification and management of poor response to growth‐promoting therapy in children with short stature

P Bang, SF Ahmed, J Argente… - Clinical …, 2012 - Wiley Online Library
Growth hormone (GH) is widely prescribed for children with short stature across a range of
growth disorders. Recombinant human (rh) insulin‐like growth factor‐1 (rhIGF‐1) therapy is …

The GH receptor exon 3 deletion is a marker of male-specific exceptional longevity associated with increased GH sensitivity and taller stature

D Ben-Avraham, DR Govindaraju, T Budagov… - Science …, 2017 - science.org
Although both growth hormone (GH) and insulin-like growth factor 1 (IGF-1) signaling were
shown to regulate life span in lower organisms, the role of GH signaling in human longevity …

Predicting growth in response to growth hormone treatment

MB Ranke, A Lindberg - Growth Hormone & IGF Research, 2009 - Elsevier
The use of growth hormone (GH) to treat children who have disturbances of growth is
complicated by variability both within and across diagnostic groups, and at the start of and …

Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH …

MJE Wassenaar, OM Dekkers… - The Journal of …, 2009 - academic.oup.com
Context: The exon-3 deleted GH receptor (GHRd3) polymorphism is associated with an
increased growth response to recombinant human GH (rhGH) therapy in some, but not all …

Idiopathic short stature: management and growth hormone treatment

JM Wit, EO Reiter, JL Ross, PH Saenger… - Growth Hormone & IGF …, 2008 - Elsevier
In the management of ISS auxological, biochemical, psychosocial and ethical elements
have to be considered. In boys with constitutional delay of growth and puberty androgens …

The growth response to growth hormone (GH) treatment in children with isolated GH deficiency is independent of the presence of the exon 3-minus isoform of the GH …

WF Blum, K Machinis, EP Shavrikova… - The Journal of …, 2006 - academic.oup.com
Context: A variant of the human GH receptor (GHR) lacks a 22-amino-acid sequence
derived from exon 3 (d3-GHR). It was reported that pediatric patients, born small for …